CSIMarket
 
Kiwa Bio tech Products Group Corp  (KWBT)
Other Ticker:  
 
 
Price: $0.0160 $-0.00 -2.439%
Day's High: $0.0171 Week Perf: -6.43 %
Day's Low: $ 0.01 30 Day Perf: -36 %
Volume (M): 3,507 52 Wk High: $ 0.09
Volume (M$): $ 56 52 Wk Avg: $0.01
Open: $0.01 52 Wk Low: $0.00



 Market Capitalization (Millions $) 0
 Shares Outstanding (Millions) 23
 Employees 1
 Revenues (TTM) (Millions $) 39
 Net Income (TTM) (Millions $) -1
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Kiwa Bio Tech Products Group Corp
We develop, manufacture, distribute and market innovative, cost-effective and environmentally safe bio-technological products for agriculture. Our products are designed to enhance the quality of human life by increasing the value, quality and productivity of crops and decreasing the negative environmental impact of chemicals and other wastes.


   KWBT is expected to report next financial results on May 17, 2021.


Customers Net Income grew by KWBT's customers Net margin grew to


8.56 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
CGA   -100%    
SANW   -100%    
MOS   -4.62%    
EMN        5.07% 
EC   -100%    
DOW   -100%    
• View Complete Report
   



Galecto Inc

Sales and Earnings Unchanged

In the first quarter of 2021 Galecto Inc of $-0.53 per share compared to $ a year ago and eps fell from $1.07 per share from the previous quarter.

Galecto Inc reported operating loss of $-13.552 millions, in the first quarter of 2021, a deterioration from the operating shortfall of $K millions, realized in first quarter of 2020

Sage Therapeutics Inc

Logged a Loss, Sales Faded

Declining demand caused increase in loss for the first quarter of 2021, company's loss per share grew to $-1.64 from $-2.44 where Sales fell by -30.75% to $1.58 millions from $2.29 millions a year ago.

In contrast to the fourth quarter by -99.86% from $1.11 billions and eps fell from $17.35 per share.

Kaleido Biosciences Inc

Kaleido Biosciences Inc announced financial first quarter of 2021 operating loss of $-22.348 millions

In the financial first quarter of 2021 Kaleido Biosciences Inc lost money of $-0.58 per share compared to $-0.64 a year ago and increased losses from $-0.56 per share from the previous quarter.

Sales remained unchanged to $0.30 millions from $0.00 millions in the same quarter a year ago and sequentially Sales improved by 22.22 % from $0.24 millions.

Seres Therapeutics Inc

Losses Widen, Sales Faded

Weak demand caused increase in losses for the fiscal time frame ending Mar 31 2021, company's deficit per share grew to $-0.39 from $-0.28 where Sales fell by -30.17% to $5.72 millions from $8.19 millions a year ago.

In contrast to the fourth quarter Sales improved by -67.44% from $17.56 millions and increased losses from $-0.20 per share.

Uwharrie Capital Corp

Blow-out Quarter

Uwharrie Capital Corp delivered very strong results in the first quarter of 2021, where Revenues soared by 93.48% to $13.95 millions, while company's earnings per share soared by 2000 % to $0.63 per share, from the same quarter a year ago.

In contrast to the fourth quarter Revenues increased by 0.07 % from $13.94 millions and income improved by 4.23 % from $0.60 per share.






 

Kiwa Bio Tech Products Group's Segments
 
 
• View Complete Report


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SNAP's Profile

Stock Price

SNAP's Financials

Business Description

Fundamentals

Charts & Quotes

SNAP's News

Suppliers

SNAP's Competitors

Customers & Markets

Economic Indicators

SNAP's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071